Cuspa

Cuspa Medical is an Israeli startup pioneering transcatheter solutions for heart valve repair, with a focus on Aortic Regurgitation (AR). Founded by Dr. Yair Feld, the company aims to improve outcomes for patients with chronic heart disease through safer, less invasive therapies. Cuspa's innovative approach addresses critical gaps in current treatments, striving to redefine standards of care and become a global leader in heart valve repair technology. Cuspa is developing an artificial cusp for use in treating aortic valve insufficiency (AI), a heart disorder in which the valve does not close properly and allows blood to flow backward into the heart. The company's CUSPER is an artificial cusp, connected to a grasper, that is attached to the native valve cusp/leaflet for the treatment of AI. Cusper is attached to the native aortic valve cusp using a nitinol grasper, it preserves the functionality of a healthy aortic and prevents valve insufficiency. After demonstrating proof of concept, Cuspa Medical is carrying out pre-clinical studies on pigs, with the objective to optimize Cusper's performance. Cuspa Medical is the first company to introduce a Transcatheter Aortic Valve Repair device, 'The Cusper,' which offers seamless integration for Aortic Valve Regurgitation.